Molecular differences in metastatic pancreatic cancer may help identify prognosis for patients, according to a study published in the Public Library of Science Medicine (2010 Jul 13;7(7):e1000307).
Patients with pancreatic cancer may benefit from therapy that combines a cancer medication and an organic compound found in broccoli, according to a study published in Cancer Research (2010 Jun 15;70(12):5004-13).
Patients with initially unresectable pancreatic cancer might experience clinical benefits from neoadjuvant therapy, according to a study published in PLoS Medicine (2010 Apr 20;7(4):e1000267).
People who consume soft drinks increase their risk of developing pancreatic cancer compared with those who do not consume soft drinks, according to a study published in Cancer Epidemiology, Biomarkers & Prevention (February 2010;19[2]:447-455).
Resistance to chemotherapy is one of the greatest challenges in pancreatic cancer treatment. However, US researchers have found that inhibiting the enzyme TAK-1 can overcome this.
Reviews the etiology, diagnosis, treatment, and palliative care associated with pancreatic cancer
